Pharsight

Protonix Iv patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6780881

(Pediatric)

WYETH PHARMS Freeze-dried pantoprazole preparation and pantoprazole injection
May, 2022

(1 year, 10 months ago)

US7351723

(Pediatric)

WYETH PHARMS Freeze-dried pantoprazole preparation and pantoprazole injection
May, 2022

(1 year, 10 months ago)

US8754108

(Pediatric)

WYETH PHARMS Freeze-dried pantoprazole preparation and pantoprazole injection
May, 2022

(1 year, 10 months ago)

Protonix Iv is owned by Wyeth Pharms.

Protonix Iv contains Pantoprazole Sodium.

Protonix Iv has a total of 3 drug patents out of which 3 drug patents have expired.

Expired drug patents of Protonix Iv are:

  • US6780881*PED
  • US7351723*PED
  • US8754108*PED

Protonix Iv was authorised for market use on 22 March, 2001.

Protonix Iv is available in injectable;intravenous dosage forms.

The generics of Protonix Iv are possible to be released after 17 May, 2022.

Drugs and Companies using PANTOPRAZOLE SODIUM ingredient

Market Authorisation Date: 22 March, 2001

Treatment: NA

Dosage: INJECTABLE;INTRAVENOUS

How can I launch a generic of PROTONIX IV before it's drug patent expiration?
More Information on Dosage

PROTONIX IV family patents

Family Patents